Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry (Sentinel)

Presenter: Han Su Park

October 27, 2024

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

Todd Neale

September 17, 2022

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Conference News TCT 2015

Endovascular Therapies for Stroke Challenge the Adage ‘Time is Brain’

October 12, 2015

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

News Conference News TCT 2012

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

October 22, 2012

News Conference News

Embolic Protection Devices for TAVR Show Promise

November 09, 2011

Advertisement

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry (Sentinel)

Comparing DCBs in De Novo CAD: Drugs, Design Matter

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

Endovascular Therapies for Stroke Challenge the Adage ‘Time is Brain’

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

Embolic Protection Devices for TAVR Show Promise

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content